The Coris FDA assent isn’t the first rodeo for Nanosonics, given its Trophon device has been commercialised since 2009. What next?

The U.S. FDA gave the green light to Nanosonics Ltd.’s Coris system via de novo clearance for reducing infection risk by delivering improved cleaning outcomes for flexible endoscopes, especially the ...

Nanosonics has received FDA De Novo clearance for its new Coris system, a technology designed to improve the cleaning of ...

Gastrointestinal procedures make up a huge share of the most commonly billed services at ASCs, according to a March 13 MedPAC ...

In an agency first, the FDA has cleared a system designed to clean out the complex inner channels of flexible endoscopes—a ...

The global infection control market was valued at $32,613.75 million in 2020, and is projected to reach $38,616.77 million by 2028, registering a CAGR of 3.0% from 2021 to 2028. The growth of the ...

The U.S. Food and Drug Administration (FDA) has announced a series of critical updates this week, reflecting its ongoing ...

Last week, "Koda," a 13-year-old male cheetah, received a thorough wellness exam as part of the Animal Health Department's ...

ASX health stocks broke their losing streak this week, while it was a big week for Nanosonics, Neurizon and Sigma.

Nanosonics shares surged after the medical equipment maker received approval from the US Food and Drug Administration (FDA) ...

Koda, a 13-year-old male cheetah at Zoo Miami, recently underwent a comprehensive wellness exam as part of the zoo’s ...

Koda,” a 13-year-old make cheetah at Zoom Miami, received a thorough wellness exam as part of the Animal Health Department’s ...